1235 related articles for article (PubMed ID: 19735755)
21. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
22. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
Lin HH; Wang LY; Hu CT; Huang SC; Huang LC; Lin SS; Chiang YM; Liu TT; Chen CL
J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
[TBL] [Abstract][Full Text] [Related]
23. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
24. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.
Ho AM; Nelson EA; Walker DG
Arch Dis Child; 2008 Jan; 93(1):52-8. PubMed ID: 17855438
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
[TBL] [Abstract][Full Text] [Related]
26. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluation of universal newborn hepatitis B vaccination in China.
Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
[TBL] [Abstract][Full Text] [Related]
30. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
Das A
Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of screening immigrants for hepatitis B.
Wong WW; Woo G; Jenny Heathcote E; Krahn M
Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
Arguedas MR; Heudebert GR; Fallon MB; Stinnett AA
Am J Gastroenterol; 2002 Mar; 97(3):721-8. PubMed ID: 11922569
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program.
Chen CC; Yen CH; Wu WY; Hu SW; Chen SC; Bell WR; Lee MC
Chin Med J (Engl); 2007 Jul; 120(13):1155-8. PubMed ID: 17637244
[TBL] [Abstract][Full Text] [Related]
36. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
37. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
39. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
40. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
Chang MH; Chen CJ; Lai MS; Hsu HM; Wu TC; Kong MS; Liang DC; Shau WY; Chen DS
N Engl J Med; 1997 Jun; 336(26):1855-9. PubMed ID: 9197213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
